Takeda Korea appoints Sun Jin Lee as head of Oncology BU

Former marketing manager of the Hemophilia BU who served as the APAC Launch & Digital Excellence Lead

Junghun Kim, former head of the Oncology BU, has been promoted to Country Manager of Malaysia & Singapore

Sun Jin (Justine) Lee, New Head of Oncology BU, Takeda Pharmaceuticals Korea

Takeda Pharmaceuticals Korea (General Manager HeeSeok Moon) announced on the 20th that it had promoted and appointed Manager Sun Jin (Justine) Lee as the Head of its Oncology BU.

 

The new head, Lee, who joined Takeda Pharmaceuticals Korea as a marketing manager of the Hemophilia BU, developed creative marketing strategies and drew participation from internal and external stakeholders for its implementation.

 

Lee played a pivotal role in improving the access and awareness of Takeda Korea's hemophilia business and demonstrated her leadership capabilities.

 

In recognition of her leadership, Lee had led the product launch in the market as a Launch & Digital Excellence Lead in the Asia Pacific (APAC) region, and also successfully carried out projects such as presenting the vision and direction for the digital transformation of Takeda in the APAC region.

 

it was recognized for its leadership capabilities, such as playing a pivotal role in improving the access and awareness of Takeda Korea's hemophilia business.

 

Since then, he has led the product launch in the market as a Launch & Digital Excellence Lead in the Asia Pacific (APAC), and at the same time ha Junghun Kim, the former head of the Oncology BU, has been appointed Country Manager of Malaysia & Singapore in May through the 'FLP(Future Leaders Program)' that provides global networking opportunities for employees within Takeda Pharmaceutical.

 

Kim joined Takeda Pharmaceuticals Korea as a marketing manager in 2015 and established the Inflammatory bowel disease and blood cancer BU.

 

After being appointed head of the Oncology BU in 2019, Lee launched various innovative oncology products in Korea and exceeded the target for three consecutive years, and has been leading the company’s digital transformation in Korea.

 

Under the value ‘Exceptional People Experience,’ Takeda Pharmaceuticals is committed to providing various experiences and opportunities for its employees to develop their capabilities.

 

It also offers special programs for select key talents.

 

The ‘FLP (Future Leaders Program)’, which provides global networking opportunities in Takeda, is one such program, and the recent personnel appointments were also made through the FLP.

 

HeeSeok Moon, General Manager of Takeda Pharmaceuticals Korea, said, “The promotion has more meaning as it was achieved by Takeda’s professional development program.

 

Takeda Pharmaceuticals Korea will continue its best efforts to support various programs for our executives and employees to develop their careers so that each and every employee may realize his or her full potential.”